(265 days)
SNUCONE Tissue Level Implant System is inticated for use in partially or fully edentulous mandibles and maxillae, in support of single or multiple-unit restorations including; cemented retained, or overdenture restorations and terminal or internediate Abutment support for fixed bridge work. Snucone implant system is dedicated for two stage surgical procedures and for immediate loading when there is good primary stability and an appropriate occlusal load. Also, implants with diameters larger than 5mm are indicated for molar regions.
SNUCONE Implant System Fixture, also known as an endosseous implant, is surgical component that interfaces with the bone of the jaw or skull to support a dental prosthesis such as a crown, bridge, denture. Snucone's abutment and prosthetic components and tools are compatible with the Snucone's fixture only. The system includes Fixtures and Cover Screw, and Abutment and Component (Solid Abutment, InOcta Closing Screw, InOcta Healing Abutment, InOcta Abutment, InOcta Angled Abutment, InOcta Temporary Abutment, Platform Switching Abutment, and Abutment Screw).
The provided text is a 510(k) premarket notification for a medical device (SNUCONE Tissue Level Implant System). It contains details about the device, its intended use, comparison to predicate devices, and a list of non-clinical tests performed. However, it does not contain information about acceptance criteria or a study that proves the device meets those criteria, especially in the context of an FDA clearance for an AI/ML-driven device.
The document explicitly states: "Bench tests were conducted to verify that the subject device met all design specifications as was Substantially Equivalent (SE) to the predicate device." It details mechanical performance, sterilization, shelf-life, packaging, MR environment conditions, bacterial endotoxin, and biocompatibility.
THERE IS NO MENTION OF AN AI/ML COMPONENT IN THIS DEVICE.
Therefore, I cannot fulfill your request for information regarding:
- A table of acceptance criteria and the reported device performance for an AI/ML component. The document describes acceptance criteria for mechanical, material, and sterilization properties, but not AI/ML performance metrics (e.g., sensitivity, specificity, AUC).
- Sample size for test set and data provenance specific to an AI/ML model. The tests mentioned are laboratory bench tests, not data-driven performance studies on patient cohorts for an AI model.
- Number of experts and their qualifications for ground truth establishment. This is not relevant to the non-clinical tests described.
- Adjudication method for the test set. Not relevant.
- MRMC comparative effectiveness study or human reader improvement. Not relevant.
- Standalone (algorithm only) performance. Not relevant.
- Type of ground truth used (expert consensus, pathology, outcomes data, etc.). Not relevant to the tests performed.
- Sample size for the training set. Not relevant, as no AI model is described.
- How ground truth for the training set was established. Not relevant, as no AI model is described.
In summary, the provided document is a 510(k) submission for a physical dental implant system and does not involve any AI/ML components or related performance studies.
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.